A Study to Assess Intrahepatic and Peripheral Changes of Immunologic and Virologic Markers in Chronic Hepatitis B Virus Infection

NCT04585789 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B

Interventions

DRUG: JNJ-73763989
DRUG: JNJ-56136379
DRUG: Entecavir (ETV)
DRUG: Tenofovir disoproxil
DRUG: Tenofovir alafenamide (TAF)
DRUG: PegIFN-alpha-2a (Optional)

Sponsor

Janssen Research & Development, LLC